Stina W.
- Country
- Sweden
- Department
- VO Hematologi, onkologi och Strålningsfysik
Research Overview
- Phase 3 Randomized Trial of Daratumumab, Bortezomib, Lenalidomide, Dexamethasone, and Ciltacabtagene Autoleucel in Transplant-Eligible Multiple Myeloma
- Phase 3 Randomized Trial of Bortezomib, Lenalidomide, Dexamethasone, and Ciltacabtagene Autoleucel in Newly Diagnosed Multiple Myeloma Without Planned Stem Cell Transplant
- Phase 3 Randomized Trial of Ciltacabtagene Autoleucel vs. Pomalidomide, Bortezomib, and Dexamethasone or Daratumumab, Pomalidomide, and Dexamethasone in Relapsed Lenalidomide-Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 115 of 181 partner sites.
Specializations
Multiple Myeloma Management
The investigator specializes in treating multiple myeloma, with particular focus on novel therapeutic approaches including CAR-T cell therapy and combination drug regimens.
- Newly Diagnosed Multiple Myeloma Treatment
- Relapsed and Refractory Multiple Myeloma
- Innovative Therapeutic Combinations
Their research encompasses both transplant-eligible and non-eligible patient populations.
Cellular Therapy
The investigator focuses on advancing cellular therapy approaches, particularly studying ciltacabtagene autoleucel as a treatment modality for multiple myeloma patients.
- CAR-T Cell Therapy Development
- Stem Cell Transplantation
- Immunotherapy Applications
Their work includes comparative studies between cellular therapies and conventional treatments.
Post-Transplant Care
The investigator studies post-transplant management, including vaccination strategies and immune reconstitution in transplant recipients.
- Post-Transplant Vaccination Timing
- HPV Prevention Strategies
- Immune System Recovery
Their research extends to optimizing outcomes in allogeneic stem cell transplant recipients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.